|
Age >60 years
|
43
|
61.4
|
8
|
42.0
|
2.2
|
0.78-6.13
| | |
|
Male gender
|
45
|
64.3
|
9
|
47.4
|
0.5
|
0.18-1.39
| | |
|
APACHE II score ≥20 at BSI onset
|
32
|
45.7
|
2
|
10.5
|
7.2
|
1.54-33.35
|
2.1
|
0.3-12.8
|
|
Organ failure (at least one)
|
59
|
84.2
|
10
|
52.5
|
4.8
|
1.60-14.60
|
2.9
|
0.6-13.2
|
|
Respiratory failure
|
54
|
77.1
|
8
|
42.1
|
4.6
|
1.60-13.50
| | |
|
Cardiovascular failure
|
35
|
50.0
|
3
|
15.8
|
5.3
|
1.43-19.95
| | |
|
Renal failure
|
29
|
41.4
|
4
|
21.0
|
2.7
|
0.80-8.82
| | |
|
Hematologic failure
|
5
|
7.1
|
-
|
-
|
1.3
|
1.15-1.45
| | |
|
Hepatic failure
|
8
|
11.4
|
-
|
-
|
1.3
|
1.16-1.47
| | |
|
Inadequate antifungal therapy
|
55
|
78.6
|
14
|
73.7
|
1.31
|
0.41-4.22
| | |
|
Charlson score ≥3
|
40
|
57.1
|
9
|
47.3
|
1.5
|
0.54-4.10
| | |
|
Neoplasia
|
20
|
28.5
|
6
|
31.5
|
0.9
|
0.29-2.60
| | |
|
SOFA at BSI onset, mean (±SD)
|
6.7 (4.3)
|
3.6 (2.3)
|
1.28
|
1.07-1.52
|
1.05
|
0.8-1.3
|
|
SAPS II at BSI onset, mean (±SD)
|
48.4 (15.4)
|
35.2 (14.3)
|
1.06
|
1.02-1.11
|
1.04
|
0.9-1.1
|
|
Time to positivity (in hours), mean (±SD)
|
43.9 (19.8)
|
34.6 (15.4)
|
1.03
|
1.0-1.06
|
1.04
|
1.0-1.1
|
